Summary of findings table ‐ Ondansetron vs placebo
Risk for at least one adverse event per patient · patients with chronic kidney disease (CKD) pruritus
It is very uncertain whether summary of findings table ‐ Ondansetron changes risk for at least one adverse event per patient compared with placebo (very low certainty).
1 finding from 1 review
- Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes onlyRR 2.54 [0.38, 16.78]3 studies · 174 participantsVery low